Browse by Section 100 Item List
HIGHLY SPECIALISED DRUGS PROGRAM (Public Hospital)
For Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule. Highly Specialised Drugs prescribed through public hospitals, except Complex Authority Required Highly Specialised Drugs, are Authority required (STREAMLINED) PBS Prescriptions. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats. Complex Authority Required Highly Specialised Drugs require written authority applications. Approval of authority prescriptions by Services Australia may be obtained either by posting an Authority Prescription Form to Services Australia, or by using the Services Australia Authority free-call service (1800 888 333). Prescribers must quote the provider number of the hospital when applying.
Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies. A patient will be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the Pharmaceutical Benefits Scheme. Commonwealth subsidy is not available for hospital in-patients.
Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.
- Legend
- MPMedical Practitioner
Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
---|---|---|---|---|---|
MP | 10183Y | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 5 |
MP | 10190H | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 4 |
MP | 10191J | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 0 |
MP | 10525Y | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 6 |
MP | 12840T | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 8 | 8 | 0 |
MP | 12877R | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 6 | 6 | 5 |
MP | 12900Y | ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial | 1 | 1 | 0 |
MP | 13276R | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 | 1 | 1 | 5 |
MP | 12936W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 | 1 | 1 | 5 |
MP | 5825N | ELTROMBOPAGeltrombopag 25 mg tablet, 28 | 1 | 28 | 5 |
MP | 5826P | ELTROMBOPAGeltrombopag 50 mg tablet, 28 | 1 | 28 | 5 |
MP | 5714R | EPOETIN ALFAepoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 5722E | EPOETIN ALFAepoetin alfa 10 000 units/mL injection, 6 x 1 mL syringes | 2 | 12 | 5 |
MP | 5719B | EPOETIN ALFAepoetin alfa 2000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 5713Q | EPOETIN ALFAepoetin alfa 20 000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 5720C | EPOETIN ALFAepoetin alfa 3000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 5721D | EPOETIN ALFAepoetin alfa 4000 units/0.4 mL injection, 6 x 0.4 mL syringes | 2 | 12 | 5 |
MP | 5718Y | EPOETIN ALFAepoetin alfa 40 000 units/mL injection, 1 mL syringe | 2 | 2 | 5 |
MP | 5715T | EPOETIN ALFAepoetin alfa 5000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 5716W | EPOETIN ALFAepoetin alfa 6000 units/0.6 mL injection, 6 x 0.6 mL syringes | 2 | 12 | 5 |
MP | 5717X | EPOETIN ALFAepoetin alfa 8000 units/0.8 mL injection, 6 x 0.8 mL syringes | 2 | 12 | 5 |
MP | 5728L | EPOETIN BETAepoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 5729M | EPOETIN BETAepoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes | 2 | 12 | 5 |
MP | 5724G | EPOETIN BETAepoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 5725H | EPOETIN BETAepoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 5726J | EPOETIN BETAepoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 5727K | EPOETIN BETAepoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 9668W | EPOETIN LAMBDAepoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 9596C | EPOETIN LAMBDAepoetin lambda 10 000 units/mL injection, 6 x 1 mL syringes | 2 | 12 | 5 |
MP | 9669X | EPOETIN LAMBDAepoetin lambda 2000 units/mL injection, 6 x 1 mL syringes | 2 | 12 | 5 |
MP | 9670Y | EPOETIN LAMBDAepoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes | 2 | 12 | 5 |
MP | 9587N | EPOETIN LAMBDAepoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes | 2 | 12 | 5 |
MP | 9589Q | EPOETIN LAMBDAepoetin lambda 5000 units/0.5 mL injection, 6 x 0.5 mL syringes | 2 | 12 | 5 |
MP | 9591T | EPOETIN LAMBDAepoetin lambda 6000 units/0.6 mL injection, 6 x 0.6 mL syringes | 2 | 12 | 5 |
MP | 9594Y | EPOETIN LAMBDAepoetin lambda 8000 units/0.8 mL injection, 6 x 0.8 mL syringes | 2 | 12 | 5 |
MP | 11065J | EPOPROSTENOLepoprostenol 1.5 mg injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack | 30 | 30 | 5 |
MP | 11090Q | EPOPROSTENOLepoprostenol 500 microgram injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack | 30 | 30 | 5 |
MP | 10117L | EPOPROSTENOLepoprostenol 1.5 mg injection, 1 vial | 30 | 30 | 5 |
MP | 10130E | EPOPROSTENOLepoprostenol 500 microgram injection, 1 vial | 30 | 30 | 5 |
MP | 13319B | ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices | 1 | 1 | 5 |
MP | 5735W | ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices | 1 | 1 | 0 |
MP | 13294Q | ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack | 2 | 2 | 5 |
MP | 5734T | ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack | 1 | 1 | 0 |
MP | 13308K | ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes | 1 | 1 | 5 |
MP | 5733R | ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes | 1 | 1 | 0 |
MP | 5738B | EVEROLIMUSeverolimus 250 microgram tablet, 60 | 2 | 120 | 5 |
MP | 5739C | EVEROLIMUSeverolimus 500 microgram tablet, 60 | 2 | 120 | 5 |
MP | 5740D | EVEROLIMUSeverolimus 750 microgram tablet, 60 | 4 | 240 | 5 |
MP | 5737Y | EVEROLIMUSeverolimus 1 mg tablet, 60 | 4 | 240 | 5 |